{"symbol":"BMY","fiscalQuarter":"Q1-2020","reportDate":"2020-05-07","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q1-2020","postBrief":{"headline":"Bristol-Myers Squibb Beats on EPS, Stock Down 0.15%","keyNumbers":[{"metric":"EPS","actual":"$1.72","expected":"N/A","surprise":"+16.37%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Bristol-Myers Squibb reported better-than-expected earnings per share, which indicates strong performance in that area. However, the stock reacted slightly negatively, declining by 0.15%. The lack of revenue data and management commentary may have contributed to the muted stock reaction.","metaDescription":"Bristol-Myers Squibb (BMY) Q1 2020 earnings: EPS beat by 16.37%. Stock down 0.15%. Full breakdown."}}